Ron Handels works as an assistant professor at the Alzheimer Centre Limburg at Maastricht University and is affiliated to the Karolinska Institutet; and is part of the International Pharmaco-Economic collaboration on Alzheimer’s Disease (www.ipecad.org). He has a background in epidemiology and cost-effectiveness analysis in Alzheimer’s disease (AD). He has published in the area of potential cost-effectiveness of diagnostics in AD and natural AD disease progression. His work has been funded by national and international funding schemes (among which H2020, JPND and IMI). On an occasional basis he has provided advisory for pharmaceutical organizations.
Support Alzheimer research at https://www.alzheimeronderzoekfondslimburg.nl/steun-ons
Keywords: Health Technology Assessment, health economics, diagnostic evaluation, Alzheimer’s disease, decision making, clinical epidemiology